Biocorrodible metals for coronary revascularization: Lessons from PROGRESS-AMS, BIOSOLVE-I, and BIOSOLVE-II

The impetus for developing drug-eluting bioresorbable scaffolds (BRS) has been driven by the need for elastic and transient platforms instead of stiff and permanent metallic implants in diseased coronary anatomies. This endeavor would prevent acute recoil or occlusion, allow sealing of post-procedur...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchi, Yasir H., Gogas, Bill D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2015
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754561/
https://www.ncbi.nlm.nih.gov/pubmed/26925408
http://dx.doi.org/10.5339/gcsp.2015.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754561/
https://www.ncbi.nlm.nih.gov/pubmed/26925408
http://dx.doi.org/10.5339/gcsp.2015.63

Ejemplares similares